Is DexCom a Millionaire Maker?
Diabetes is a global epidemic, with more than 537 million people affected worldwide. (NASDAQ: DXCM) has improved patient lives with technology, and the stock has outperformed the stock market since the company went public. But today, DexCom stock is sitting well below its all-time highs.
The stock recently plunged on a disappointing earnings report. All companies eventually face adversity. If the company can bounce back, the uncertainty can create tremendous investment opportunities, even life-changing wealth.
So, is DexCom a potential millionaire maker to buy the dip on, or are the stock's recent struggles a red flag to avoid?
Source Fool.com
Dexcom Inc. Aktie
71,40 €
-1,11 %
Die Community unterstützt Dexcom Inc. stark, mit vielen Buy- und wenigen Sell-Einschätzungen.
Das Kursziel von 75 € für Dexcom Inc. impliziert eine leichte Steigerung gegenüber dem aktuellen Kurs von 71.4 €.
